{"id":52922,"date":"2025-09-10T01:38:24","date_gmt":"2025-09-10T05:38:24","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/novo-nordisk-to-slash-9000-jobs-globally-in-major-restructuring-aiming-for-1-3-billion-in-savings-by-2026\/52922\/"},"modified":"2025-09-10T01:38:24","modified_gmt":"2025-09-10T05:38:24","slug":"novo-nordisk-to-slash-9000-jobs-globally-in-major-restructuring-aiming-for-1-3-billion-in-savings-by-2026","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novo-nordisk-to-slash-9000-jobs-globally-in-major-restructuring-aiming-for-1-3-billion-in-savings-by-2026\/52922\/","title":{"rendered":"Novo Nordisk to Slash 9,000 Jobs Globally in Major Restructuring, Aiming for $1.3 Billion in Savings by 2026"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) announced a global workforce reduction of 9,000 jobs<\/strong>, with 5,000 of those cuts in Denmark, as part of a significant restructuring effort.<\/li>\n<li>The pharmaceutical giant aims to <strong>save approximately $1.3 billion (8 billion Danish crowns) annually by the end of 2026<\/strong> through these measures.<\/li>\n<li>The restructuring is a strategic response to <strong>intensifying competition, particularly from rival Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>)<\/strong>, and a need to streamline operations and reinvest in core growth areas like diabetes and obesity treatments.<\/li>\n<li>The company has also <strong>lowered its 2025 earnings forecast<\/strong> following these announcements, signaling a challenging period ahead.<\/li>\n<\/ul>\n<p>Danish pharmaceutical powerhouse Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) has unveiled a sweeping global restructuring plan that includes the elimination of <strong>9,000 jobs<\/strong> worldwide. The move is designed to streamline operations and generate substantial cost savings, with the company targeting approximately <strong>$1.3 billion (8 billion Danish crowns)<\/strong> in annual savings by the close of <strong>2026<\/strong>.<\/p>\n<p>Of the total job cuts, <strong>5,000 positions are slated to be eliminated in Denmark<\/strong>, where the company has a significant presence. This strategic overhaul comes as Novo Nordisk faces mounting pressure from intensifying competition, most notably from its U.S. rival Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>), in the lucrative diabetes and obesity treatment markets.<\/p>\n<p>The company stated that the reorganization is critical to accelerate decision-making and reallocate resources towards high-growth potential areas within its key therapeutic segments. This proactive measure follows a period where Novo Nordisk had already implemented a global hiring freeze and canceled new hire contracts as part of broader cost-cutting initiatives.<\/p>\n<p>In conjunction with the restructuring announcement, Novo Nordisk has also revised its <strong>2025 earnings forecast downwards<\/strong>, a move that reflects the anticipated one-off net costs of <strong>8 billion Danish kroner<\/strong> associated with the restructuring program. The company&#39;s operating profit growth forecast at constant exchange rates (CER) has been adjusted to <strong>4-10 percent<\/strong>, down from a previous <strong>10-16 percent<\/strong>. This marks the second downward adjustment to its profit outlook within a short period, highlighting the challenges the company is navigating.<\/p>\n<p>CEO Mike Doustdar emphasized the necessity of these difficult decisions for the company&#39;s long-term success, stating that the company needs to evolve its approach to become &quot;faster and more agile&quot; in a dynamic market environment. The savings generated from these cuts are expected to be reinvested into further strengthening its position in the diabetes and obesity treatment sectors.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novo Nordisk (NVO) announced a global workforce reduction of 9,000 jobs, with 5,000 of those cuts in Denmark, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[10428,3744,5677,6088,6163,6334,6761,8412,10426,10427],"class_list":["post-52922","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-cer","tag-nvo","tag-job-cuts","tag-restructuring","tag-diabetes","tag-novo-nordisk","tag-eli-lilly","tag-pharmaceutical","tag-cost-savings","tag-obesity"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/52922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=52922"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/52922\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=52922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=52922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=52922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}